Casey Laycock: Spotlight on Community Champion – Jon Schneider of Spire
Casey Laycock, Campaign Development Manager at Blood Cancer United, shared a post on LinkedIn:
“Spotlight on Community Champion: Jon Schneider of Spire
I’m thrilled to celebrate Jon Schneider, whose dedication to the St. Louis community continues to make a real and lasting impact. Whether he’s rolling up his sleeves as a regular platelet donor for pediatric blood cancer patients or lending his voice and leadership to local causes, Jon leads with heart, humility, and purpose.
This year, we’re especially grateful to have Jon serve as a 2026 Light The Night – St. Louis Executive Committee Member, helping to lead the way for Blood Cancer United. His commitment to giving back-and his hands-on support for families facing blood cancer-perfectly reflects the spirit of Light The Night and our mission.
Please join me in thanking Jon for shining so brightly for our community. We’re incredibly fortunate to have leaders like him lighting the path forward.
If you’re interested in becoming an executive champion for change, you can connect with me directly at [email protected]”
Stay updated with Hemostasis Today.
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same
-
Jun 28, 2026, 19:05Andrea Cesari: Comparing Catheter-Based Reperfusion Strategies for Intermediate-High-Risk PE
-
Jun 28, 2026, 19:02Nassim Emteir: Interpreting TSAT with Ferritin to Guide Iron Deficiency Diagnosis and Treatment
-
Jun 28, 2026, 19:00Andrew Jackson: Predicting PICC-Related Venous Thrombosis in Patients Undergoing Radiotherapy
-
Jun 28, 2026, 10:34Heghine Khachatryan: Menarche as the First ‘Bleeding Challenge’
-
Jun 28, 2026, 10:13Mohammed Alharbi: Assessing Warfarin Management and Anticoagulation Quality in Older Populations
-
Jun 28, 2026, 10:03Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients